Provided herein are quinazoline compounds of formula (I) for treatment of JAK kinase mediated diseases, including JAK2 kinase-, JAK3 kinase- or TYK2 kinase-mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.
申请公布号
WO2012030948(A1)
申请公布日期
2012.03.08
申请号
WO2011US49950
申请日期
2011.08.31
申请人
AMBIT BIOSCIENCES CORPORATION;HADD, MICHAEL, J.;HOLLADAY, MARK, W.;ROWBOTTOM, MARTIN
发明人
HADD, MICHAEL, J.;HOLLADAY, MARK, W.;ROWBOTTOM, MARTIN
